OtherArticle
Improvement of the Oral Drug Absorption of Topotecan through the Inhibition of Intestinal Xenobiotic Efflux Transporter, Breast Cancer Resistance Protein (BCRP), by Excipients
Tetsuo Yamagata, Hiroyuki Kusuhara, Mariko Morishita, Kozo Takayama, Hassan Benameur and Yuichi Sugiyama
Drug Metabolism and Disposition April 19, 2007, DOI: https://doi.org/10.1124/dmd.106.014217
Tetsuo Yamagata
Hiroyuki Kusuhara
Mariko Morishita
Kozo Takayama
Hassan Benameur
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Improvement of the Oral Drug Absorption of Topotecan through the Inhibition of Intestinal Xenobiotic Efflux Transporter, Breast Cancer Resistance Protein (BCRP), by Excipients
Tetsuo Yamagata, Hiroyuki Kusuhara, Mariko Morishita, Kozo Takayama, Hassan Benameur and Yuichi Sugiyama
Drug Metabolism and Disposition April 19, 2007, DOI: https://doi.org/10.1124/dmd.106.014217
OtherArticle
Improvement of the Oral Drug Absorption of Topotecan through the Inhibition of Intestinal Xenobiotic Efflux Transporter, Breast Cancer Resistance Protein (BCRP), by Excipients
Tetsuo Yamagata, Hiroyuki Kusuhara, Mariko Morishita, Kozo Takayama, Hassan Benameur and Yuichi Sugiyama
Drug Metabolism and Disposition April 19, 2007, DOI: https://doi.org/10.1124/dmd.106.014217
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement